FMP

FMP

Enter

Johnson & Johnson Exceeds Q4 Expectations with Strong Oncology Demand

-

twitterlinkedinfacebook
blog post cover photo

Image credit: FMP

Johnson & Johnson (NYSE:JNJ) delivered fourth-quarter results that surpassed Wall Street expectations, driven by robust demand for its cancer treatments and strategic acquisitions. The pharmaceutical giant also provided an upbeat forecast for 2025, projecting full-year sales of $90.9 billion to $91.7 billion and adjusted earnings per share of $10.75 to $10.95, both above analyst estimates.

Revenue for the quarter climbed 5.3% year-over-year to $22.52 billion, bolstered by a remarkable 19% increase in oncology drug sales. The multiple myeloma therapy Darzalex led the charge, with sales surging nearly 21% to over $3 billion.

The company's recent $13.1 billion acquisition of Shockwave Medical contributed $258 million to quarterly revenue, further strengthening its top-line performance.

Adjusted earnings for the quarter came in at $2.04 per share, slightly down from the prior year due to a $0.22 impairment charge linked to the acquisition of V-Wave, a medical device maker. Despite this, the earnings figure beat analyst projections of $2.01.

Other Blogs

May 27, 2024 3:30 PM - Rajnish Katharotiya

The best 5 GPU stocks other than NVDA

In the ever-evolving world of technology, certain sectors have consistently demonstrated exceptional growth and innovation. The graphics processing units (GPUs) industry is one such sector, offering investors a golden opportunity for potentially high returns. In this blog, we'll delve into why inves...

blog post title

Jun 6, 2024 2:47 AM - Parth Sanghvi

ROE vs ROA: Which Metric is More Important for Investors?

ROE vs. ROA: Which Metric is More Important for Investors? When evaluating a company's financial performance, investors often rely on various metrics to gauge profitability and efficiency. Two commonly discussed metrics are Return on Equity (ROE) and Return on Assets (ROA). Understanding the diff...

blog post title

Jun 6, 2024 2:57 AM - Parth Sanghvi

DCF vs NPV: Which Valuation Method Should You Use?

When it comes to valuing an investment or a business, two of the most commonly used methods are Discounted Cash Flow (DCF) and Net Present Value (NPV). Both methods are essential tools in finance, but they serve slightly different purposes and are used in different contexts. This guide will explore ...

blog post title
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep